… of patients with hepatocellular carcinoma (HCC), an extremely common malignant tumor in
… was observed could be partly corrected by interferon and, to a lesser extent, by levamisole. …

… In our study the combination of levamisole with IFN-a was not associated with an
enhanced rate of response in patients with low basal disease activity. On the basis of these …

… to cirrhosis and hepatocellular carcinoma. In … levamisole was administered with IFN to obtain
an immunostimulatory and an antiviral effect simultaneously. In previous reports, levamisole …

… We found that levamisole treatment of mice causes a threefold increase in production of
interferon (IFN) α/β by adherent NPC (more than 80%–90% Kupffer cells) in vitro. When IFN α/β …

… of HBsAg-containing hepatocytes, but levamisole in the short term did not … levamisole does
not appear to be beneficial. Its value in conjunction with anti-viral agents, such as interferon …

… According to these promising data, the second aim of the present study was to examine
the efficacy of IFN plus 5-FU as adjuvant therapy for stage III colon cancer in a 2 × 2 factorial …

… In the same way, previous studies reported that Tau inhibited the proliferation and induced
apoptosis of human hepatocellular carcinoma HepG2 cells and human colon cancer cells …

… IL-2) and β-interferon (β-IFN), 15 patients with colorectal cancer and 10 patients with
hepatocellular carcinoma were treated with the following outpatient schedule: β-IFN 3 × 10 6 U im 3 …

… of cancer reported levamisole clinical activity and survival benefit associated with levamisole
… no significant benefit until the recent North Central Cancer Treatment Group (NCCTG) and …

… Two HBsAg-positive individuals who had not been treated with interferon (IFN) developed
hepatic nodules which that showed dysplasia, AFP elevation and chromosomal changes. …